How much does Sequence Bio cost for biotech companies?

Sequence Bio uses contact sales pricing, meaning costs vary based on specific needs and usage requirements. Biotechnology firms need to contact their sales team directly to get custom pricing quotes tailored to their genomic analysis volume, features needed, and collaboration requirements.

What features does Sequence Bio offer for genomic research?

Sequence Bio provides genomic data analysis, disease signal identification, clinical trial support, data visualization tools, and a collaboration platform for researchers. These features help research institutions and biotech companies analyze genetic data to discover potential drug targets and biomarkers.

Sequence Bio

discovering disease signals for life-changing drugs

ReviewedContact_salesProduct

Visit website

Compare →

Shyft Score

Directory quality rating

Reviewed

43/100

Quiet

Found in 1 source

Our take

The verdict on Sequence Bio

AI-generated

Sequence Bio specializes in genomic data analysis and disease signal identification, but its pricing model is unclear and it lacks AI/agent support.

Strengths

Genomic data analysis
Disease signal identification
Clinical trial support

Limitations

Pricing unclear
No AI/agent support

Best for: Biotech and pharmaceutical companies focused on genomic research and drug development.

Request a demo to evaluate Sequence Bio for your team.

See how Sequence Bio fits your stack

Benefits

Why teams choose Sequence Bio

Identify promising drug targets faster with automated genomic analysis

Reduce clinical trial risks by discovering validated disease biomarkers

Accelerate research timelines through seamless team collaboration

Make data-driven decisions with clear visualization of complex genomic patterns

About

What is Sequence Bio?

Sequence Bio analyzes genomic data to identify disease signals and biomarkers. It supports clinical trials and offers data visualization tools. Researchers can collaborate on the platform to discover drug targets.

Key capabilities

Genomic data analysis

Disease signal identification

Clinical trial support

Data visualization tools

Collaboration platform for researchers

At a glance

What you can do with Sequence Bio

Analyze genomic data to identify disease-associated variants and biomarkers

Develop machine learning algorithms to predict disease progression and treatment response

Collaborate with pharmaceutical partners to discover and validate novel drug targets

Leverage natural language processing to extract insights from scientific literature and clinical trial data

Design and synthesize novel compounds for therapeutic applications

Best for

Pharmaceutical companiesBiotechnology firmsResearch institutions

Pricing

Sequence Bio pricing

Sequence Bio starts at contact_sales

Starting at contact_sales

Ecosystem

Connected ecosystem

MCP servers, AI skills, and integrations that work with Sequence Bio

Integrations

LabWareOracle ClinicalMedidata SolutionsSASRStudioTableauSlackMicrosoft Teams

FAQs

Frequently asked questions

Common questions about Sequence Bio and its capabilities

Sequence Bio helps pharmaceutical companies discover disease signals for drug development through genomic data analysis and disease signal identification. The platform supports clinical trials and provides data visualization tools, enabling pharma companies to identify promising therapeutic targets and accelerate drug discovery processes.